Cargando…
Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens
BACKGROUND: Routine clinical management of breast cancer (BC) currently depends on surrogate subtypes according to estrogen- (ER) and progesterone (PR) receptor, Ki-67, and HER2-status. However, there has been growing demand for reduced immunohistochemistry (IHC) turnaround times. The Xpert® Breast...
Autores principales: | Janeva, Slavica, Parris, Toshima Z., Nasic, Salmir, De Lara, Shahin, Larsson, Karolina, Audisio, Riccardo A., Bagge, Roger Olofsson, Kovács, Anikó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059293/ https://www.ncbi.nlm.nih.gov/pubmed/33879115 http://dx.doi.org/10.1186/s12885-021-08171-2 |
Ejemplares similares
-
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer
por: Janeva, Slavica, et al.
Publicado: (2023) -
Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases
por: Janeva, Slavica, et al.
Publicado: (2023) -
Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018
por: Nyqvist, Jenny, et al.
Publicado: (2020) -
Concordance of RT-qPCR with immunohistochemistry and its beneficial role in breast cancer subtyping
por: Li, Yilun, et al.
Publicado: (2023) -
Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
por: Wirtz, Ralph M., et al.
Publicado: (2016)